BMEA Q1 2026 Earnings NarrowerthanExpected Loss Highlights Progress in Clinical Pipeline Reviva Pharmaceuticals RVPH Q1 2026 Earnings NarrowerthanExpected Loss Highlights Cost Discipline Amid PreRevenue Stage Tuya Q1 2026 Earnings EPS Falls Just Short of Estimates Stock Unchanged Nathans Famous Inc NATH Q4 2024 Earnings EPS of 096 Reported as Stock Moves Lower Sui Group Holdings SUIG Q1 2026 Earnings Massive EPS Miss Amidst Market Uncertainty QUCY Q4 2023 Earnings Narrowing Losses as Mainz Biomed Advances Colorectal Cancer Screening Pipeline